跳转至内容
Merck
CN
  • Pancreatic Cell Fate Determination Relies on Notch Ligand Trafficking by NFIA.

Pancreatic Cell Fate Determination Relies on Notch Ligand Trafficking by NFIA.

Cell reports (2018-12-28)
Marissa A Scavuzzo, Jolanta Chmielowiec, Diane Yang, Katrina Wamble, Lesley S Chaboub, Lita Duraine, Burak Tepe, Stacey M Glasgow, Benjamin R Arenkiel, Christel Brou, Benjamin Deneen, Malgorzata Borowiak
摘要

Notch is activated globally in pancreatic progenitors; however, for progenitors to differentiate into endocrine cells, they must escape Notch activation to express Neurogenin-3. Here, we find that the transcription factor nuclear factor I/A (NFIA) promotes endocrine development by regulating Notch ligand Dll1 trafficking. Pancreatic deletion of NFIA leads to cell fate defects, with increased duct and decreased endocrine formation, while ectopic expression promotes endocrine formation in mice and human pancreatic progenitors. NFIA-deficient mice exhibit dysregulation of trafficking-related genes including increased expression of Mib1, which acts to target Dll1 for endocytosis. We find that NFIA binds to the Mib1 promoter, with loss of NFIA leading to an increase in Dll1 internalization and enhanced Notch activation with rescue of the cell fate defects after Mib1 knockdown. This study reveals NFIA as a pro-endocrine factor in the pancreas, acting to repress Mib1, inhibit Dll1 endocytosis and thus promote escape from Notch activation.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
单克隆抗 β-肌动蛋白抗体 小鼠抗, clone AC-15, ascites fluid
Sigma-Aldrich
抗磷酸组蛋白H3(Ser10)抗体,有丝分裂标记, Upstate®, from rabbit
Sigma-Aldrich
抗-波形蛋白抗体, serum, Chemicon®
Sigma-Aldrich
抗 α-淀粉酶 兔抗, fractionated antiserum, lyophilized powder